Clincosm LogoSign in Get a demo

Advanced Cancer

Showing NaN - NaN of 17
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Cancer, Solid Tumors, Advanced Cancer Trial in United States (ASP9801, Pembrolizumab)

Recruiting
  • Metastatic Cancer
  • +2 more
  • ASP9801
  • Pembrolizumab
  • Birmingham, Alabama
  • +26 more
Jan 6, 2023

Advanced Cancer, Melanoma, NSCLC Trial in Worldwide (BMS-986205, Nivolumab, Ipilimumab)

Completed
  • Advanced Cancer
  • +2 more
  • Tucson, Arizona
  • +46 more
Aug 18, 2022

Advanced Cancer, End Stage Organ Failure Trial in United States (Nurse-led telephonic case management, Facilitated,outpatient

Active, not recruiting
  • Advanced Cancer
  • End Stage Organ Failure
  • Nurse-led telephonic case management
  • Facilitated,outpatient specialty palliative care
  • Los Angeles, California
  • +17 more
Aug 16, 2022

Advanced Malignancies, Advanced Cancer Trial in United States (ASP7517, Pembrolizumab)

Recruiting
  • Advanced Malignancies
  • Advanced Cancer
  • Atlanta, Georgia
  • +3 more
Aug 2, 2022

Urothelial Carcinoma, Urothelial Carcinoma Bladder, Bladder Cancer Trial in United States (IK-175, IK-175 and nivolumab)

Recruiting
  • Urothelial Carcinoma
  • +20 more
  • Gilbert, Arizona
  • +9 more
Feb 3, 2022

Advanced Cancer, Ovarian Cancer, Breast Cancer Trial in United States (COM701, COM701 with Opdivo (Nivolumab).)

Recruiting
  • Advanced Cancer
  • +9 more
  • COM701
  • COM701 with Opdivo (Nivolumab).
  • Los Angeles, California
  • +10 more
Jan 25, 2022

Advanced Cancer, Metastatic Cancer, Malignant Neoplastic Disease Trial in United States (MRTX849, TNO155)

Active, not recruiting
  • Advanced Cancer
  • +2 more
  • Los Angeles, California
  • +11 more
Nov 12, 2021

Solid Tumor, Advanced Cancer, Metastatic Cancer Trial in Los Angeles, Chicago, Morristown (Q702)

Recruiting
  • Solid Tumor
  • +2 more
  • Los Angeles, California
  • +3 more
Jul 29, 2021

Advanced Cancer Trial in United States (Mocetinostat - 50 mg, Mocetinostat - 70 mg, Mocetinostat - 90 mg)

Terminated
Has Results
  • Advanced Cancer
  • Mocetinostat - 50 mg
  • +4 more
  • Mobile, Alabama
  • +14 more
Mar 10, 2021

Advanced Cancer Trial in Korea, Republic of, United States (MGCD516)

Unknown status
  • Advanced Cancer
  • Birmingham, Alabama
  • +42 more
Jan 28, 2020

Advanced Cancer, Advanced Malignancies Trial in Australia, Spain, United States (Cemiplimab, Hypofractionated radiotherapy,

Completed
  • Advanced Cancer
  • Advanced Malignancies
  • Gilbert, Arizona
  • +46 more
Jan 23, 2020

Lymphoma, Refractory Solid Tumors, Advanced Cancer Trial in United States (ASP4132)

Completed
  • Lymphoma
  • +2 more
  • New Haven, Connecticut
  • +4 more
May 31, 2019

Advanced Cancer Trial in Canada, Korea, Republic of, United States (MGCD265)

Completed
  • Advanced Cancer
  • Duarte, California
  • +18 more
Feb 11, 2019

Advanced Cancer Trial in Chicago, Evanston (Irinotecan)

Completed
  • Advanced Cancer
  • Chicago, Illinois
  • +1 more
Jan 3, 2017

Advanced Cancer, Metastatic Cancer Trial in Chicago (Rapamycin (liquid), Bevacizumab, Rapamycin (Tablets))

Completed
  • Advanced Cancer
  • Metastatic Cancer
  • Rapamycin (liquid)
  • +2 more
  • Chicago, Illinois
    University of Chicago
Jan 16, 2014

Advanced Cancer Trial in Chicago (Rapamycin)

Completed
  • Advanced Cancer
  • Chicago, Illinois
    University of Chicago
Jan 16, 2014

Advanced Cancer Trial in Chicago (Rapamycin, Ketoconazole)

Completed
  • Advanced Cancer
  • Chicago, Illinois
    University of Chicago
Jan 16, 2014